Language
Lilly’s heart drug study shows potential for once-a-year dosing

Blog

HomeHome / Blog / Lilly’s heart drug study shows potential for once-a-year dosing
search

Feb 21, 2025

Dear Doctor: What are the risks of taking proton-pump inhibitors for an extended period of time? - oregonlive.com

Feb 21, 2025

ETV7 limits the antiviral and antitumor efficacy of CD8+ T cells by diverting their fate toward exhaustion | Nature Cancer

Feb 21, 2025

90 Day Fiance’s Larissa Lima Diagnosed With Major Depressive Disorder, Taking Social Media Break

Feb 22, 2025

Effects of organic salts of virucidal and antiviral compounds from Nelumbo nucifera and Kaempferia parviflora against SARS-CoV-2 | Scientific Reports

Feb 22, 2025

Epigenetic inhibitors show promise in malaria treatment

Send your inquiry
SUBMIT

Apr 01, 2025

Lilly’s heart drug study shows potential for once-a-year dosing

Phase 2 re­sults on Eli Lil­ly’s ex­per­i­men­tal heart dis­ease drug showed it could be dosed far less fre­quent­ly than com­pet­ing treat­ments in de­vel­op­ment from No­var­tis … Get free access to

Phase 2 re­sults on Eli Lil­ly’s ex­per­i­men­tal heart dis­ease drug showed it could be dosed far less fre­quent­ly than com­pet­ing treat­ments in de­vel­op­ment from No­var­tis …

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.